Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / COMMON STOCK, PAR VALUE $0.001 PER SHARE
-
Number of holders
-
14
-
Total 13F shares, excl. options
-
271K
-
Shares change
-
+128K
-
Total reported value, excl. options
-
$510K
-
Value change
-
+$241K
-
Number of buys
-
7
-
Number of sells
-
-5
-
Price
-
$1.89
Significant Holders of Genprex, Inc. - COMMON STOCK, PAR VALUE $0.001 PER SHARE (GNPX) as of Q2 2024
17 filings reported holding GNPX - Genprex, Inc. - COMMON STOCK, PAR VALUE $0.001 PER SHARE as of Q2 2024.
Genprex, Inc. - COMMON STOCK, PAR VALUE $0.001 PER SHARE (GNPX) has 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 271K shares
.
Largest 10 shareholders include ARMISTICE CAPITAL, LLC (218K shares), GEODE CAPITAL MANAGEMENT, LLC (16.5K shares), VANGUARD GROUP INC (15.3K shares), BlackRock Inc. (11.4K shares), Tower Research Capital LLC (TRC) (3.9K shares), BROWN BROTHERS HARRIMAN & CO (2.5K shares), MORGAN STANLEY (1.49K shares), GROUP ONE TRADING, L.P. (828 shares), BANK OF AMERICA CORP /DE/ (429 shares), and Nemes Rush Group LLC (250 shares).
This table shows the top 14 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.